Enzymedica – Trademark Portfolio
Entity Type: 03
Enzymedica holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include REDUCE, PH-BASIC, MEMORYCELL, STEM XCELL, and THERACTIVE. The owner is based in Port Charlotte, FL.
752 Tamiami Tr
Port Charlotte, FL 33953
Showing of trademarks Trademarks
Trademark Classifications
Enzymedica's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Enzymedica have?
Enzymedica has 20 U.S. trademarks filed with the USPTO. Of these, 8 registered, 6 abandoned, 6 cancelled.
What trademark classes does Enzymedica file in?
Enzymedica files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Enzymedica's most well-known trademarks?
Enzymedica's registered trademark portfolio includes well-known marks such as REDUCE, PH-BASIC, MEMORYCELL, STEM XCELL, and THERACTIVE. These are among 8 currently registered trademarks in the portfolio.
What is Enzymedica's trademark registration success rate?
Enzymedica has a 40% trademark registration rate, with 8 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.